SEC Form 4 · accession 0001645627-17-000050
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 28, 2017
Accepted (ET)
May 2, 2017 · 11:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0859 | A | 20,509,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.08 | A | 20,510,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.08 | A | 20,511,449 | D | |
| Common Stock | Apr 28, 2017 | P | 44 | $0.076 | A | 20,511,493 | D | |
| Common Stock | Apr 28, 2017 | P | 956 | $0.078 | A | 20,512,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.074 | A | 20,513,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.0773 | A | 20,514,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,515,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,516,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,517,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,518,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,519,449 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.078 | A | 20,520,449 | D | |
| Common Stock | Apr 28, 2017 | P | 500 | $0.0835 | A | 20,520,949 | D | |
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.089 | A | 20,521,949 | D |
Table II — derivative securities
No Table II lines on this filing.